Aripazine reverses unfractionated and low molecular weight heparins, fondaparinux and new Xa and IIa oral anticoagulants: report of Phase I/II clinical trial with edoxaban Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ansell, JE
  • Laulicht, B
  • Bakhru, S
  • Steiner, S
  • Noveck, R
  • Brown, K
  • Grosso, M
  • Morishima, Y
  • Dishy, V
  • Mercuri, Mat

publication date

  • September 1, 2014